HiFiBiO Therapeutics lands $67 mln Series C

HiFiBiO Therapeutics, a biotherapeutics company, has secured $67 million in Series C financing. IDG Capital led the round.

28 August 2019•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.